Cost effectiveness analysis of a hypertension management program in patients with type 2 diabetes
- PMID: 19302422
- PMCID: PMC8673129
- DOI: 10.1111/j.1751-7176.2009.00082.x
Cost effectiveness analysis of a hypertension management program in patients with type 2 diabetes
Erratum in
- J Clin Hypertens (Greenwich). 2009 Jul;11(7):404. Alex, Fu Z [corrected to Fu, Alex Z]; Christopher, Hebert [corrected to Hebert, Christopher]
Abstract
Hypertension is a costly disease; however, the investment needed for a cost-neutral hypertension management program (HMP) is unknown. A Markov decision analytic model simulated the outcomes of a hypothetical HMP. Patients were between the ages of 25 and 65 years, had existing hypertension, and were newly diagnosed with diabetes. The control group received standard care. The HMP group received standard care and were enrolled in an HMP. Data regarding rates of disease states and costs were gathered from the literature. A third-party payer can invest as much as $159, $109, and $41 per person per month in an HMP for a neutral return on investment in the 5-year, 3-year, and 1-year time horizon, respectively. The HMP group achieved greater gains in quality-adjusted life-years and lower total health-related costs. As the time horizon increases, more money can be invested. HMPs can be a cost-effective and cost-neutral proposition.
Figures
References
-
- Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the united states 1999 to 2000: a rising tide. Hypertension. 2004;44:398–404. - PubMed
-
- Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–1252. - PubMed
-
- Lewington S, Clarke R, Qizilbash N, et al. Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. - PubMed
-
- Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–2093. - PubMed
-
- Artinian NT, Flack JM, Nordstrom CK, et al. Effects of nurse‐managed telemonitoring on blood pressure at 12‐month follow‐up among urban african americans. Nurs Res. 2007;56:312–322. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
